In this retrospective cohort analysis of 36 patients with TP53 , the authors showed a trend for longer overall survival in monoallelic patients as compared to multi-hit patients following HSCT.
← all excerpts
How I Treat <i>TP53</i>-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes.
1
—
—